Market Overview

According to IMARC Group's latest research publication, "Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034", The global animal health market size was valued at USD 40.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 51.6 Billion by 2034, exhibiting a growth rate (CAGR) of 2.73% during 2026-2034.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

How AI is Reshaping the Future of the Animal Health Market

• AI-Powered Disease Diagnostics: Artificial intelligence is revolutionizing veterinary diagnostics by enabling faster and more accurate identification of diseases in livestock and companion animals, reducing misdiagnosis rates and improving treatment outcomes.
• Predictive Health Analytics: Machine learning models analyze biometric data from wearable sensors on animals, predicting illness onset before visible symptoms appear — enabling proactive intervention and reducing mortality rates in commercial livestock operations.
• Automated Drug Discovery: AI platforms are accelerating R&D pipelines for veterinary pharmaceuticals by simulating molecular interactions and predicting drug efficacy, significantly cutting time-to-market for novel animal health therapeutics.
• Smart Farm Management: AI-integrated farm management systems use real-time data to monitor herd behavior, nutrition, and reproductive health, helping producers optimize yields while reducing antibiotic usage in livestock.
• Telemedicine and Remote Monitoring: AI-driven veterinary telemedicine platforms allow pet parents to access specialized care remotely, while diagnostic algorithms help triage cases and support veterinarians in underserved rural areas globally.

Download a sample PDF of this report: https://www.imarcgroup.com/animal-health-market/requestsample

Key Trends in the Animal Health Market

• Increasing Focus on Preventive Healthcare: The animal health industry is experiencing a significant shift toward preventive healthcare practices for both companion animals and livestock. Pet parents and livestock producers recognize the importance of early detection and proactive management. India's Livestock Health and Disease Control Schemes (₹525 crore budget) and One Health initiatives are expanding preventive coverage globally.
• Advancements in Biotechnology and Pharmaceuticals: Swift progress in biotechnology is changing how animal diseases are diagnosed and treated. Gene editing, PCR, DNA sequencing, and cell therapies are creating targeted solutions. QBiotics' STELFONTA (tigilanol tiglate) — approved by Australia's APVMA — marks a landmark in canine oncology therapeutics.
• Growing Pet Humanization and Specialty Care: Pets are increasingly considered family members, transforming consumer behavior. In the US, 35% of adults aged 24–35 have adopted or plan to adopt a pet. This drives premium nutrition, activity-tracking devices, and personalized veterinary treatments.
• Rise of Veterinary Telemedicine: Digital health platforms and telemedicine are expanding access to veterinary consultations, particularly in underserved regions. Remote diagnostics and AI-assisted triage tools are improving care efficiency and convenience for pet parents worldwide.
• Surge in Zoonotic Disease Awareness: Rising outbreaks of zoonotic infections are driving demand for vaccines, diagnostics, and antimicrobial therapies. Collaborative One Health initiatives between veterinary and human healthcare sectors are strengthening disease surveillance and biosecurity investments globally.

Growth Factors in the Animal Health Market

• Rising Pet Adoption and Humanization: In 2024, 66% of US households own a pet. Pet parents are spending significantly more on premium veterinary care, nutrition, and specialty health products, fueling consistent market expansion.
• Expanding Livestock Sector and Food Security Demand: The rising global demand for protein-rich diets is driving livestock producers to invest in preventive health measures. India's total meat production reached 10.25 million tons in 2023-24, up 4.85% over a decade, amplifying demand for veterinary health solutions.
• Government Regulations and Biosecurity Initiatives: Governments worldwide are implementing stricter animal health regulations to ensure food safety and control zoonotic diseases. Programs like the US FDA's antimicrobial stewardship and India's G20 Pandemic Fund (USD 25 million) are stimulating market investments.
• Innovation in Pharmaceuticals and Biologics: Pharmaceutical companies are investing heavily in R&D for advanced vaccines, targeted biologics, and precision therapies. For example, Elanco's FDA-approved Zenrelia™ (ilunocitinib) targets canine dermatology with a safer, more effective treatment approach.
• Strategic Mergers and Acquisitions: Industry consolidation is accelerating innovation. In February 2024, Merck Animal Health acquired Elanco's aqua business outside the US and Canada for USD 1.3 billion, expanding its portfolio of medicines, vaccines, and nutritional supplements for aquatic species.

Ask analyst of customized report: https://www.imarcgroup.com/request?type=report&id=1156&flag=E

Leading Companies Operating in the Global Animal Health Industry

• Bayer
• Elanco
• Merck
• Merial
• Zoetis Inc.
• Biogenesis Bago
• Boehringer Ingelheim
• Ceva Sante Animale
• Heska
• Neogen
• Novartis
• Thermo Fisher Scientific
• Vetoquinol
• Virbac

Animal Health Market Report Segmentation

Breakup By Animal Type:

• Commercial: Encompasses livestock and poultry reared for commercial needs (milk, meat, eggs). Producers invest in preventive healthcare, vaccinations, and disease management to optimize productivity and profitability.
• Companion: Driven by rising pet humanization, Gen Z/Millennial pet parents, and increased spending on premium veterinary services, specialty diets, and health monitoring devices.

Commercial segment dominates due to the large-scale healthcare requirements of livestock and poultry operations globally.

Breakup By Product Type:

• Pharmaceuticals (57.0% share in 2025): Largest segment; addresses disease prevention and treatment for pets and farm animals with innovative controlled-release formulations and targeted medicines.
• Biologicals: Vaccines and biologics providing immunity against infectious diseases; growing rapidly due to advances in recombinant and DNA vaccine technologies.
• Medicinal Feed Additives: Nutritional supplements and growth promoters integrated into animal feed to improve productivity and disease resistance.
• Diagnostics: Rapid diagnostic tools enabling early disease detection; advanced MRI, CT imaging, PCR, and DNA sequencing platforms improving disease management outcomes.

Breakup By Region:

• North America (44.9% share, 2025): Largest market, led by the US (86.5% of North American share). Driven by high pet ownership, strong pharmaceutical R&D ecosystem, and robust government regulations.
• Asia Pacific: Fastest-growing region, fueled by rising meat consumption, expanding livestock sectors in China and India, and growing urban pet populations.
• Europe: Strong market driven by animal welfare regulations, large livestock populations (Spain holds 25.4% of EU pig population), and high-quality veterinary standards.
• Latin America: Expanding livestock exports drive growth; Brazil exported 5.138 million tons of poultry products in 2023. Urban pet adoption also rising.
• Middle East and Africa: Growing demand for livestock products and rising pet ownership (UAE had 928.4 million pets in 2023) are catalyzing market investments.

Recent News and Developments in the Animal Health Market

• January 2025: Ceva Animal Health secured rights to produce and launch products using Touchlight's dbDNA technology in the animal health sector, aiming to develop innovative DNA vaccines for animals.
• November 2024: MSD Animal Health (Merck & Co.) announced the European Commission's approval of BRAVECTO® TriUNO, a new chewable tablet for dogs targeting both internal and external parasites.
• October 2024: The Indian government announced a USD 25 million G20 Pandemic Fund to enhance livestock health coverage in response to pandemics, to be executed with ADB, World Bank, and FAO by August 2026.
• September 2024: Elanco announced the FDA approval and launch of Zenrelia™ (ilunocitinib tablets), a targeted treatment for canine dermatological conditions, improving quality of life for affected dogs.
• February 2024: Merck Animal Health acquired Elanco Animal Health's aqua business (outside US/Canada) for USD 1.3 billion, expanding its aquatic species health portfolio including medicines, vaccines, and manufacturing facilities in Canada and Vietnam.

Note: If you require specific details, data, or insights not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements.

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302